SELLAS Life Sciences
SLS
#5226
Rank
โ‚น158.89 B
Marketcap
โ‚น808.09
Share price
5.96%
Change (1 day)
448.01%
Change (1 year)

Earnings for SELLAS Life Sciences (SLS)

Earnings in 2025 (TTM): -โ‚น2.48 Billion

According to SELLAS Life Sciences's latest financial reports the company's current earnings are N/A. , an increase over its 2024 earnings that were of -โ‚น2.99 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for SELLAS Life Sciences from 2007 to 2025

Annual earnings

Year Earnings Change
2025 -โ‚น2.68 Billion-10.28%
2024 -โ‚น2.99 Billion-16.78%
2023 -โ‚น3.59 Billion-9.73%
2022 -โ‚น3.98 Billion65.85%
2021 -โ‚น2.4 Billion48.95%
2020 -โ‚น1.61 Billion-1.31%
2019 -โ‚น1.64 Billion-44.65%
2018 -โ‚น2.95 Billion45.99%
2017 -โ‚น2.02 Billion-33.17%
2016 -โ‚น3.02 Billion-6.87%
2015 -โ‚น3.25 Billion-30.98%
2014 -โ‚น4.7 Billion46.52%
2013 -โ‚น3.21 Billion
2011 -โ‚น1.6 Billion
2008 -โ‚น1.38 Billion27.51%
2007 -โ‚น1.09 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-โ‚น13.55 Billion 405.78%๐Ÿ‡บ๐Ÿ‡ธ USA